"My friend lost more weight on Zepbound" is not clinical evidence
Medicaid programs in North Carolina, South Carolina, Michigan, New Hampshire, and California have announced plans to eliminate or narrow access to GLP-1 weight-loss treatment in some cases limiting it only to people who are morbidly obese. The reversal reflects tightening budgets, slowing revenue growth, and rising spending demands
Rapid weight loss can trigger skin irritation, dehydration-related reactions, or fungal issues in skin folds, all of which may appear as rash independent of semaglutide
We will post our most current Policy on this page with the last updated date, and you should periodically visit this page to review it
The recovery process will vary from woman to woman